Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Waldenström
What is the response of the immune system when patients with chronic lymphocytic leukemia
are vaccinated with the Shingrix herpes zoster vaccine?
Basic Study Information
Purpose:Study Reference #: ULYM18094
The purpose of this study is to measure humoral response 4 weeks after vaccination
with the Shingrix herpes zoster vaccine in patients with CLL and WM undergoing first-line
treatment with BTK inhibitors.
Lead Researcher (Principal Investigator)
Lead Researcher: Jonathan Friedberg, MD
Study Contact InformationStudy Coordinator: Delaney Dretto
Phone: (585) 275-5825
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search